Participant guide
Informed consent explained
Informed consent starts with a conversation, and the signature is only one piece of it. It is how you learn what a CNS clinical trial involves before you decide whether to take part, for yourself or for someone you care for.
Updated
What you are told
A written consent document is handed to you to read before you agree to any part of a CNS study, and the study team explains the study itself first. Expect that document to spell out:
- the study's purpose and its length;
- your part in it, from visits to tests;
- discomforts and risks that are already known;
- any benefits that could reasonably be expected;
- the alternatives you have if you do not join;
- the way your details are kept confidential;
- the people to reach when a question or concern comes up.
Take your time
The document is yours to take home. Read it there, go over it with family or your own doctor, and put every question you have to the study team. Start with this list of questions worth asking.
Consent is ongoing
Your signature on the consent document for a CNS study does not tie you in. No contract is created by it, and you stay free to walk away from the study whenever you choose. Should something come to light mid-study that could change how you feel about taking part, the team is required to share it with you.
Talk with a study coordinator
Call (888) 520-7418, or send the short form if you prefer. A coordinator then explains which CNS studies could suit you and lays out the step that follows. You can ask anything without taking on any obligation.
Sources and further reading
- About Research Participation — HHS Office for Human Research Protections
- Clinical Research: Benefits, Risks, and Safety — National Institute on Aging (NIH)
- 45 CFR 46 — Protection of Human Subjects — U.S. Department of Health and Human Services